Overview
AI drug design platform; now part of Recursion.
Details
Exscientia’s Centaur Chemist platform pioneered AI-designed clinical candidates. Merged into Recursion in 2024.
AI drug design platform; now part of Recursion. Exscientia's Centaur Chemist platform pioneered AI-designed clinical candidates. Merged into Recursion in 2024.
AI drug design platform; now part of Recursion.
Exscientia’s Centaur Chemist platform pioneered AI-designed clinical candidates. Merged into Recursion in 2024.
Turn AI reports into shareable sites
Publish reports & dashboards as websites
Make AI-generated reports public, stable, and easy to update — free to start.
Try Revdoku →